Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy
NCT00756041
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
221
Enrollment
INDUSTRY
Sponsor class
Stopped
Lack of Efficacy.
Conditions
Diabetic Neuropathies
Interventions
DRUG:
TAK-128
Sponsor
Takeda